Skip to main content
. Author manuscript; available in PMC: 2017 Nov 22.
Published in final edited form as: Handb Exp Pharmacol. 2009;(188):165–196. doi: 10.1007/978-3-540-71029-5_8

Table 3A.

Phenotypic analyses of murine DC subsets

DC subseta % Total DCs* CD11c B220 (CD45R) CD8α CD19 120G8 CCR6 B71/2 (CD80/86) References
Myeloid (mDCs) ~50% high Int. Inducible (Shortman and Naik 2007)
Plasmacytoid (pDCs) ~40% low + + + low Inducible (Asselin-Paturel et al. 2003)
IDO-competent (CD19+) pDCs 5–10% high + + + high high (Mellor et al. 2004)
(Mellor et al. 2005)
(Baban et al. 2005)
(Manlapat et al. 2007)
a

Based on analyses of murine splenic DCs.